InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the complete record of transactions filed by Martin Daniel C., Directeur Commercial. Insider active across 1 company, notably Deciphera Pharmaceuticals, Inc.. In total, 7 filings have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €32k. History available since 15 December 2021. The latest transaction was filed on 16 June 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
1,311 shares@ US$10.7542.3% of flowCommon StockSEC:0001209191-22-038428:0
1,146 shares@ US$9.0528.9% of flowCommon StockSEC:0001209191-22-011359:0
1,146 shares@ US$9.05100.0% of flowCommon StockSEC:0001209191-22-011359
13,667 shares0Common StockSEC:0001209191-22-004077
13,667 shares0Common StockSEC:0001209191-22-004077:0
8,300 shares0Common StockSEC:0001209191-21-070226
8,300 shares0Common StockSEC:0001209191-21-070226:0
7 of 7 declarations
About Martin Daniel C.
Daniel C. Martin is the Chief Commercial Officer at Deciphera Pharmaceuticals, Inc., a biopharmaceutical company. He is responsible for commercial strategy and business development. His expertise in the pharmaceutical sector allows him to lead initiatives aimed at increasing the reach and impact of the company's products in the market.
